Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Gains from Investment Securities (2021 - 2025)

Prime Medicine filings provide 5 years of Gains from Investment Securities readings, the most recent being $539000.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 98.81% to $539000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $432000.0, a 99.04% decrease, with the full-year FY2025 number at $432000.0, down 99.04% from a year prior.
  • Gains from Investment Securities hit $539000.0 in Q4 2025 for Prime Medicine, up from -$83.9 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $83.8 million in Q1 2025 to a low of -$83.9 million in Q3 2025.
  • Median Gains from Investment Securities over the past 5 years was $3.0 million (2023), compared with a mean of $5.9 million.
  • The widest YoY moves for Gains from Investment Securities: up 1421.55% in 2024, down 623.96% in 2024.
  • Prime Medicine's Gains from Investment Securities stood at $2.2 million in 2021, then soared by 1223.37% to $28.6 million in 2022, then tumbled by 89.55% to $3.0 million in 2023, then soared by 1421.55% to $45.5 million in 2024, then plummeted by 98.81% to $539000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $539000.0 (Q4 2025), -$83.9 million (Q3 2025), and $83.8 million (Q1 2025) per Business Quant data.